DrugDashboards

Desmopressin Acetate

Desmopressin Acetate · DESMOPRESSIN ACETATE 4 ug/mL · Injection, Solution · Intravenous · Caplin Steriles Limited

NDC 65145-0183-10 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 1 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.6% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for desmopressin acetate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · price up 13% YoY

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $181.50 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA219981
TE code
AP
Approval date
Feb 27, 2026
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Desmopressin Acetate (Injection, Solution)

LabelerStrengthFirst seenLast seen
Fresenius Kabi USA, LLCDESMOPRESSIN ACETATE 4 ug/mLJul 15, 2026Sep 3, 2026
Sun Pharmaceutical Industries LimitedDESMOPRESSIN ACETATE 4 ug/mLJul 15, 2026Sep 3, 2026
Sun Pharmaceutical Industries, Inc.DESMOPRESSIN ACETATE 4 ug/mLJul 15, 2026Sep 3, 2026
XGen Pharmaceuticals DJB, Inc.DESMOPRESSIN ACETATE 4 ug/mLJul 15, 2026Sep 3, 2026
Armas Pharmaceuticals Inc.DESMOPRESSIN ACETATE 4 ug/mLJul 15, 2026Sep 2, 2026
Armas Pharmaceuticals Inc.DESMOPRESSIN ACETATE 40 ug/10mLJul 15, 2026Sep 2, 2026
Avenacy, Inc.DESMOPRESSIN ACETATE 4 ug/mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.DESMOPRESSIN ACETATE 4 ug/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsDESMOPRESSIN ACETATE 40 ug/10mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsDESMOPRESSIN ACETATE 4 ug/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedDESMOPRESSIN ACETATE 4 ug/mLJul 15, 2026Aug 31, 2026
The J. Molner Company LLCDESMOPRESSIN ACETATE 4 ug/mLAug 15, 2026Aug 29, 2026
Caplin Steriles LimitedDESMOPRESSIN ACETATE 4 ug/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Desmopressin Acetate — NDC 65145-0183-10," retrieved September 3, 2026, https://drugdashboards.com/drug/65145018310.

Free to cite with attribution — see how the data is put together.